Abstract
In the latest ESUR contrast media guidelines, standard prophylaxis is no longer recommended for patients with moderate chronic kidney disease (CKD). In the absence of solid evidence, guideline updates are often based on indirect evidence and expert opinion. Likewise, evidence supporting the withdrawal of standard prophylaxis in moderate CKD patients was scarce and mostly indirect, but did include one randomised controlled trial evaluating guideline-recommended standard prophylactic intravenous hydration against a group receiving no prophylaxis (A MAastricht Contrast-Induced Nephropathy Guideline (AMACING) trial). Since then, benefits of the updated guideline recommendation for patient and hospital burden have been numerated and were shown to be substantial. The current special report provides data on long-term safety from the AMACING randomised controlled trial.
Original language | English |
---|---|
Pages (from-to) | 627-632 |
Number of pages | 6 |
Journal | European Radiology |
Volume | 33 |
Issue number | 1 |
Early online date | 28 Jun 2022 |
DOIs | |
Publication status | Published - Jan 2023 |
Keywords
- Contrast media
- Acute kidney injury
- Chronic kidney disease
- Prophylaxis
- Clinical practice guidelines
- IODINATED CONTRAST MATERIAL
- PROTECT RENAL-FUNCTION
- HYDRATION
- RISK